Institut Allergosan

What Institut Allergosan does

Institut AllergoSan Pharma GmbH is a privately held, family-run Austrian company founded in January 1991 in Graz, operating as a competence centre for microbiome research. It develops, manufactures, and markets consumer health products built on probiotic bacterial strains, prebiotic fibers, plant extracts, and minerals, organized around the multi-brand portfolio OMNi-BiOTiC® (multi-species synbiotic probiotics), OMNi-LOGiC® (prebiotic fibers and the WH67® humic-acid medical device), META-CARE® (micronutrients), and Caricol® (patented papaya-based digestive supplement). Differentiated technology includes multi-strain synbiotic formulations stable at temperatures up to 40°C, a patented papaya preparation process that multiplies papain activity fourfold, and proprietary WH67® humic acid for gut-barrier support.

The company serves three primary customer segments: end-consumers seeking gut, immune, skin, pregnancy, and stress-related support; healthcare professionals (pharmacists, doctors, therapists, dietitians) reached through the Fachakademie/Darmakademie professional education platform and certified Fachberater für Darmgesundheit program; and pet owners addressed via the OMNi-BiOTiC® CAT & DOG line. Revenue is generated through one-time unit-priced retail sales via pharmacy partners across the DACH region, direct-to-consumer e-commerce on country-specific storefronts covering 20+ international markets, and a Swiss distribution partnership with Spagyros AG. The firm does not disclose revenue, has no external investors or parent company, and is led by founder/Managing Director Mag. Anita Frauwallner.

Name

Institut Allergosan

Legal name

Institut AllergoSan Pharma GmbH

Website

https://allergosan.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

101–250 employees

Short description

Institut AllergoSan is a privately held, family-run Austrian microbiome research company that develops, manufactures, and sells probiotic, prebiotic, micronutrient, and papaya-based digestive supplements under the OMNi-BiOTiC®, OMNi-LOGiC®, META-CARE®, and Caricol® brands, distributed through DACH pharmacies and 20+ international markets.

Ownership category

akta.pro rank

Product category

Probiotic & Microbiome Health Supplements

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Dog and Cat Food Manufacturing (311111)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Probiotics & Digestive Health Supplements (CRADAGAF)

akta.pro secondary industries

Probiotics (Strains, Spore-Formers, Synbiotic Components) (AFAJAKAE), Prebiotics & Dietary Fibers (Inulin, FOS/GOS, Resistant Starch, Beta-Glucan, Psyllium) (AFAJAKAF), Nutraceuticals & Functional Ingredients for Animal Diets (Probiotics, Omega-3, Joint, GI) (HLAMAHAH)

Keywords

• Probiotic supplements
• Gut health products
• Microbiome research
• Synbiotic formulations
• Digestive health

Headquarters

HQ city

Graz

HQ country

Austria

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Consumer health product sales: Revenue is generated through the sale of proprietary probiotic (OMNi-BiOTiC®), prebiotic (OMNi-LOGiC®), and micronutrient (META-CARE®) products, papaya-based digestive aids (Caricol®), and pet probiotic supplements (OMNi-BiOTiC® CAT & DOG). Products are sold through pharmacy partners, direct-to-consumer e-commerce, and online pharmacy reservation platforms. Pricing includes consumer retail price points (e.g., Caricol® 20 sticks at €25.90 UVP). The company operates across DACH and international markets via country-specific online storefronts.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels9 records

Core offering

Institut AllergoSan develops, researches, and manufactures probiotic (synbiotic), prebiotic, and micronutrient health products with a primary focus on intestinal and gut health. Its portfolio includes OMNi-BiOTiC® multi-species synbiotic probiotics, OMNi-LOGiC® fiber/prebiotic supplements, META-CARE® micronutrients, Caricol® papaya-based digestive aids, OMNi-BiOTiC® CAT & DOG pet probiotics, and skin care lines such as Caricol®-Derma Sensitiv and OMNi-BiOTiC® SKiN®.

Product overview

Institut AllergoSan is a competence center for microbiome research that develops, researches, and markets health products made from natural substances including probiotic bacteria, plant extracts, and minerals. The company operates a multi-brand portfolio organized around three core product categories: OMNi-BiOTiC® (multispecies synbiotic probiotics with various bacterial strains), OMNi-LOGiC® (natural fiber and prebiotic supplements), and META-CARE® (micronutrient supplements with plant extracts). Additional offerings include Caricol® (papaya-based digestive products), OMNi-POWER® (mineral and energy supplements), and Dr. med. Schütze® (dental care products). Specialized sub-brands include OMNi-BiOTiC® SKiN® for probiotic skincare and OMNi-BiOTiC® CAT & DOG for pet probiotics. The company also offers targeted formulations such as Caricol®-Derma Sensitiv for skin care and OMNi-LOGiC® HUMIN for digestive support.

Differentiator

Problem solved

Functional benefit

Products and services

• OMNi-BiOTiC® Multi-species synbiotic probiotic products designed to colonize the intestines with beneficial bacteria including lactobacilli, lactococci, and bifidobacteria, combined with specifically coordinated prebiotic fibers. Stable up to 40°C and formulated for indications including general gut health, antibiotic-associated diarrhea, traveler's diarrhea, pregnancy, and stress.
• OMNi-LOGiC® Natural fiber and prebiotic supplements that serve as food source for beneficial gut bacteria (bifidobacteria and lactobacilli) to support microbiome balance, complementing the OMNi-BiOTiC® probiotics.
• META-CARE® High-quality micronutrient brand combining vitamins, minerals, trace elements, and plant extracts for targeted nutritional support, including products such as Gut Balance, Zinc Plus, Vitamin C, Selenium, and Osteo Fit.
• Caricol® Natural papaya-based digestive supplement containing the enzyme papain, produced from tree-ripened fruits using a patented preparation method delivering four times higher papain activity than raw papaya puree. Available in 7-stick, 20-stick, and 42-stick formats (priced at €9.50, €25.90, and €48.90 UVP respectively).
• OMNi-BiOTiC® CAT & DOG Probiotic developed for cats and dogs to stabilize sensitive animal gut flora, particularly during travel, stress, or digestive illness. Contains Enterococcus faecium DSM 10663/NCIMB 10415 and Lactobacillus acidophilus CECT 4529 strains combined with Mannan-Oligosaccharides (MOS) fiber, delivering at least 1.25 billion live and viable bacteria per minimum daily dose.
• OMNi-LOGiC® HUMIN Medical device containing WH67® humic acid extracted from German lignite (brown coal) for binding harmful substances and toxins in the human intestine, forming a protective film that seals mucous membranes and reaches areas inaccessible to activated charcoal.
• Caricol®-Derma Sensitiv Medical skincare product made from natural ingredients including patented papaya and oat preparations, coconut oil, and neem leaf extract, formulated for skin irritation, redness, itching, and dry skin.
• OMNi-BiOTiC® SKiN® Probiotic skincare product line applying microbiome science to topical skin health, representing a new generation of probiotic-based dermatological skin care.
• OMNi-BiOTiC® ViTAL Product combining natural ingredients and science, featuring an electrolyte complex for cellular energy support within the OMNi-BiOTiC® range.
• OMNi-POWER® Mineral and energy supplements developed by professional athletes and nutrition scientists, formulated for maximum tolerability.
• Dr. med. Schütze® Dental care product line including ParoMIT Q10 spray for oral health.

Quantifiable outcome

• In a study of 264 travelers, only 12% of synbiotic users experienced traveler's diarrhea symptoms, despite many traveling to high-risk countries (>50% probability). In Egypt (≥80% traveler's diarrhea probability), over 90% of travelers were protected by the synbiotic product.
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Spagyros AG (Switzerland)coreChannel Partner/ Reseller/ Distributor · 1 January 1991Spagyros AG serves as the Swiss distributor for Institut AllergoSan products, operating the Swiss German (de-ch) and Swiss French (fr-ch) versions of the company website. The partnership enables distribution of OMNi-BiOTiC®, OMNi-LOGiC®, META-CARE®, and Caricol® products in the Swiss market. Contact: [email protected].
• WESEO InternetagenturminorOthersWESEO Internetagentur (T: +43 800 400 877, [email protected]) is responsible for the concept, web design, and technical implementation of Institut AllergoSan's websites.
• INRED AgencyminorOthersINRED is listed as the agency responsible for Institut AllergoSan's digital presence.
• Austrian Development Aid / Sri Lankan small farmersminorOthersCaricol® papaya fruits are sourced from small farmers and family businesses in Sri Lanka. The processing of biological papaya fruits in Sri Lanka is supported by Austrian Development Aid. Farmers receive prices above the usual market rate, securing a better quality of life for their families. This sourcing model supports the company's fair-trade positioning.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat5 records

Key highlights2 records

Customer concentration

• YouTubeyoutube.com/playlist?list=PLMp7AgHxB5iWDqp3kB4NVaN6y6dRLKo4P
• Facebookfacebook.com/allergosan
• LinkedInlinkedin.com/company/allergosan

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institut Allergosan